Free Trial

Totally (TLY) Competitors

Totally logo
GBX 8.55 -0.70 (-7.56%)
As of 12:06 PM Eastern

TLY vs. KNB, SPI, MGP, SBI, ORPH, CREO, KOO, REDX, ETX, and VLG

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Open Orphan (ORPH), Creo Medical Group (CREO), Kooth (KOO), Redx Pharma (REDX), e-therapeutics (ETX), and Venture Life Group (VLG). These companies are all part of the "medical" sector.

Totally vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, community ranking, analyst recommendations and earnings.

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 51.3% of Totally shares are owned by institutional investors. 37.0% of Kanabo Group shares are owned by insiders. Comparatively, 13.3% of Totally shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M4.99-£8.18M-£0.01-90.00
Totally£106.68M0.16-£3.13M-£0.02-427.55

Totally has a consensus price target of GBX 20, indicating a potential upside of 133.89%. Given Totally's stronger consensus rating and higher possible upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Totally'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

Kanabo Group has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.

Kanabo Group has a net margin of 0.00% compared to Totally's net margin of -2.94%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo GroupN/A -83.19% -20.89%
Totally -2.94%-8.85%-2.42%

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%

Summary

Totally beats Kanabo Group on 9 of the 15 factors compared between the two stocks.

Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£16.81M£1.51B£5.39B£2.04B
Dividend Yield13.16%3.92%5.37%5.16%
P/E Ratio-427.55111.2988.831,926.65
Price / Sales0.1639.511,284.83384,006.48
Price / Cash9.0812.5136.6029.21
Price / Book0.502.154.963.08
Net Income-£3.13M£55.02M£117.89M£183.60M
7 Day Performance-7.56%-0.65%2.74%3.09%
1 Month Performance12.51%0.72%3.63%3.42%
1 Year Performance82.91%8.53%27.26%165.41%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
N/AGBX 8.55
-7.6%
GBX 20
+133.9%
+95.8%£16.81M£106.68M-427.551,668
KNB
Kanabo Group
N/AGBX 0.88
+10.0%
N/A-60.9%£5.57M£1.14M-88.0020
SPI
Spire Healthcare Group
2.8122 of 5 stars
GBX 226
+0.7%
GBX 322
+42.5%
+4.4%£912.63M£1.44B3,228.57420News Coverage
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179
CREO
Creo Medical Group
N/AGBX 18.06
-2.4%
N/A-56.0%£65.34M£30.30M-301.00279News Coverage
KOO
Kooth
3.0889 of 5 stars
GBX 176.15
-3.4%
GBX 585
+232.1%
-38.4%£64.26M£54.17M1,467.92478Positive News
High Trading Volume
REDX
Redx Pharma
N/AN/AN/AN/A£58.35M£4.20M-150.00101Gap Up
High Trading Volume
ETX
e-therapeutics
N/AN/AN/AN/A£52.59M£295,000.00-450.0035High Trading Volume
VLG
Venture Life Group
N/AGBX 37.86
-0.4%
N/A+4.3%£48.10M£51.41M3,786.20165

Related Companies and Tools


This page (LON:TLY) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners